Nelfinavir Mesylate and Olaratumab Intravenous

• Generic Name: nelfinavir
• Dosage Forms: n.a.
• Other Brand Names: Viracept

Treatment of HIV-1 infection in adults, adolescents, and pediatric patients ≥2 years of age; usually used in conjunction with 2 HIV nucleoside reverse transcriptase inhibitors (NRTIs).

Experts state nelfinavir not recommended for initial treatment regimens in antiretroviral-naive adults and adolescents because of inferior virologic efficacy and high incidence of diarrhea.

For initial treatment in antiretroviral-naive pediatric patients, experts state nelfinavir in conjunction with 2 NRTIs can be considered in children ≥2 years of age, but only in special circumstances when preferred or alternative regimens cannot be used. Safety and efficacy not established in those <2 years of age, and not recommended in this age group because of insufficient data.

• Generic Name: olaratumab
• Dosage Forms: n.a.
• Other Brand Names: Lartruvo

Olaratumab injection is used in combination with doxorubicin to treat soft tissue sarcoma (STS) in patients who cannot be cured with radiation therapy or surgery, and need to be treated with an anthracycline-containing regimen. Olaratumab interferes with the growth of tumor, which are eventually destroyed by the body.

Olaratumab is to be given only by or under the direct supervision of your doctor.